Molecule Structure

Scientific Name


Description of the Drug

Isoniazid is an antibiotic used to treat mycobacterial infections; most commonly use in combination with other antimycobacterial agents for the treatment of active or latent tuberculosis.

Source: DrugBank Online – Retrieved 2023-03-10 from

Brand Name(s)

Dow-isoniazid, Hyzyd, Isoniazid, Laniazid, Nicotibine, Nydrazid, Rimifon, Stanozide

Company Owner(s)

Thepharmanetwork Llc, Sun Pharmaceutical Industries Inc, Halsey Drug Co Inc, Watson Laboratories Inc, Cmp Pharma Inc, Nexgen Pharma Inc, Purepac Pharmaceutical Co, Novartis Pharmaceuticals Corp, Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa, Impax Laboratories Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Enoyl-[acyl-carrier-protein] reductase SINGLE PROTEIN INHIBITOR CHEMBL1849

Unichem Links

Atlas isoniazid
PharmGKB PA450112
Human Metabolome Database HMDB0015086
DrugBank DB00951
PubChem: Thomson Pharma 15321438
PubChem 3767
Mcule MCULE-6324947959
NMRShiftDB 20097187
LINCS LSM-6682 LSM-46042
Nikkaji J1.371D
BindingDB 50336507
EPA CompTox Dashboard DTXSID8020755
DrugCentral 1497
Brenda 208021 93732 93730 51707 2409 44273 851 10677 93729 10678
ChemicalBook CB5102053
PubChem: Drugs of the Future 92309394
KEGG Ligand C07054
ChEBI 6030
ZINC ZINC000000001590